INmune Bio has dosed the first patient in its Phase 1b trial (NCT03943264) testing the safety and efficacy of its next-generation anti-inflammatory compound XPro1595 for Alzheimer’s disease (AD). The trial is currently recruiting in different sites across Australia. More information can be found here. Instead of targeting amyloid plaques — or clumps of misfolded proteins […]

Cell therapy is becoming established as a modality that has the potential to substantially improve the treatment of a wide range of diseases. This collection features reviews on cell -based therapies for cancer, autoimmune disorders and inherited blood diseases, highlighting the technological advances such as CRISPR-based gene editing and improved viral vectors that have provided […]

For nursing students at Bunker Hill Community College in Boston, it’s one thing to learn from an instructor or from written material, but it’s far more valuable to interact with a live patient, particularly when it comes to pediatrics, where the patient might not be able to articulate their symptoms as well as an adult […]